IGI Logo

Panacea Biotec is currently trading at Rs. 446.25, up by 11.70 points or 2.69% from its previous closing of Rs. 434.55 on the BSE.

The scrip opened at Rs. 456.25 and has touched a high and low of Rs. 456.25 and Rs. 446.10 respectively. So far 22166 shares were traded on the counter.

The BSE group 'T' stock of face value Rs. 1 has touched a 52 week high of Rs. 489.00 on 12-Dec-2024 and a 52 week low of Rs. 112.70 on 04-Jun-2024.

Last one week high and low of the scrip stood at Rs. 469.00 and Rs. 410.00 respectively. The current market cap of the company is Rs. 2762.10 crore.

The promoters holding in the company stood at 72.87%, while Institutions and Non-Institutions held 1.53% and 25.60% respectively.

Panacea Biotec has received a Letter of Award (LoA) from UNICEF for supply of 115 million doses of its bivalent oral polio vaccine (bOPV) worth around $14.95 million (around Rs 127 crore) in CY2025.

The supply of bOPV to UNICEF is for its requirements in countries in Africa / Asia region as per the orders as may be received from time to time.

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.